Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project

Introduction: Metabolic disorders are common amongst HIV-infected patients. Data from real-life setting on the impact of DTG/ABC/3TC in virologically suppressed HIV-infected patients are scarce. Methods: We investigated the modification of metabolic profile including fasting glucose, lipid profile a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Infect Drug Resist
Hlavní autoři: Bagella, Paola, Squillace, Nicola, Ricci, Elena, Gulminetti, Roberto, De Socio, Giuseppe Vittorio, Taramasso, Lucia, Pellicanò, Giovanni, Menzaghi, Barbara, Celesia, Benedetto Maurizio, Dentone, Chiara, Orofino, Giancarlo, Bonfanti, Paolo, Madeddu, Giordano
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6536892/
https://ncbi.nlm.nih.gov/pubmed/31213857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S203813
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky